Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Trias

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
European Urology Open Science|June 18, 2025
Corrigendum to "Prognostic Expression Signature of <i>RB1</i>, <i>PTEN</i>, and <i>TP53</i> Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors" [Eur. Urol. Open Sci. 70 (2024) 86-90]Marta Garcia de Herreros, Natalia Jiménez, Leonardo Rodríguez-Carunchio, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 1, 2024
Whole-Exome Sequencing of Vulvar Squamous Cell Carcinomas Reveals an Impaired Prognosis in Patients With TP53 Mutations and Concurrent CCND1 GainsOriol Ordi, Adela Saco, Núria Peñuelas, et al.
Cancers|June 22, 2023
P53 in Penile Squamous Cell Carcinoma: A Pattern-Based Immunohistochemical Framework with Molecular CorrelationIsabel Trias, Adela Saco, Lorena Marimon, et al.
The American Journal of Surgical Pathology|July 23, 2024
p53 Immunohistochemistry Defines a Subset of Human Papillomavirus-Independent Penile Squamous Cell Carcinomas With Adverse PrognosisIsabel Trias, Ferran Algaba, Inés de Torres, et al.
The American Journal of Surgical Pathology|December 10, 2024
p53 Immunohistochemistry Defines a Subset of Human Papillomavirus-independent Penile Squamous Cell Carcinomas With Adverse PrognosisIsabel Trias, Ferran Algaba, Inés de Torres, et al.
International Journal of Cancer|October 10, 2022
Differential etiopathogenic features of vulvar squamous cell carcinomas in sub-Saharan Africa and EuropeNatalia Rakislova, Nuria Carreras-Dieguez, Carolina Manzotti, et al.
International Journal of Molecular Sciences|January 11, 2022
Pathogenesis of Penile Squamous Cell Carcinoma: Molecular Update and Systematic ReviewInmaculada Ribera-Cortada, José Guerrero-Pineda, Isabel Trias, et al.
International Journal of Molecular Sciences|July 12, 2025
Clinical and Transcriptomic Characterization of Metastatic Hormone-Sensitive Prostate Cancer Patients with Low PTEN ExpressionMarta Garcia de Herreros, Natalia Jiménez, Joan Padrosa, et al.
European Urology Oncology|May 27, 2025
Corrigendum to "Development and independent validation of a prognostic gene expression signature based on RB1, PTEN, and TP53 in metastatic hormone-sensitive prostate cancer patients" [Eur. Urol. Oncol. 7 (2024) 954-964]Natalia Jiménez, Marta Garcia de Herreros, Òscar Reig, et al.
European Urology Oncology|March 1, 2024
Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer PatientsNatalia Jiménez, Marta Garcia de Herreros, Òscar Reig, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
European Urology Open Science|June 18, 2025
Corrigendum to "Prognostic Expression Signature of <i>RB1</i>, <i>PTEN</i>, and <i>TP53</i> Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors" [Eur. Urol. Open Sci. 70 (2024) 86-90]Marta Garcia de Herreros, Natalia Jiménez, Leonardo Rodríguez-Carunchio, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 1, 2024
Whole-Exome Sequencing of Vulvar Squamous Cell Carcinomas Reveals an Impaired Prognosis in Patients With TP53 Mutations and Concurrent CCND1 GainsOriol Ordi, Adela Saco, Núria Peñuelas, et al.
Cancers|June 22, 2023
P53 in Penile Squamous Cell Carcinoma: A Pattern-Based Immunohistochemical Framework with Molecular CorrelationIsabel Trias, Adela Saco, Lorena Marimon, et al.
The American Journal of Surgical Pathology|July 23, 2024
p53 Immunohistochemistry Defines a Subset of Human Papillomavirus-Independent Penile Squamous Cell Carcinomas With Adverse PrognosisIsabel Trias, Ferran Algaba, Inés de Torres, et al.
The American Journal of Surgical Pathology|December 10, 2024
p53 Immunohistochemistry Defines a Subset of Human Papillomavirus-independent Penile Squamous Cell Carcinomas With Adverse PrognosisIsabel Trias, Ferran Algaba, Inés de Torres, et al.
International Journal of Cancer|October 10, 2022
Differential etiopathogenic features of vulvar squamous cell carcinomas in sub-Saharan Africa and EuropeNatalia Rakislova, Nuria Carreras-Dieguez, Carolina Manzotti, et al.
International Journal of Molecular Sciences|January 11, 2022
Pathogenesis of Penile Squamous Cell Carcinoma: Molecular Update and Systematic ReviewInmaculada Ribera-Cortada, José Guerrero-Pineda, Isabel Trias, et al.
International Journal of Molecular Sciences|July 12, 2025
Clinical and Transcriptomic Characterization of Metastatic Hormone-Sensitive Prostate Cancer Patients with Low PTEN ExpressionMarta Garcia de Herreros, Natalia Jiménez, Joan Padrosa, et al.
European Urology Oncology|May 27, 2025
Corrigendum to "Development and independent validation of a prognostic gene expression signature based on RB1, PTEN, and TP53 in metastatic hormone-sensitive prostate cancer patients" [Eur. Urol. Oncol. 7 (2024) 954-964]Natalia Jiménez, Marta Garcia de Herreros, Òscar Reig, et al.
European Urology Oncology|March 1, 2024
Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer PatientsNatalia Jiménez, Marta Garcia de Herreros, Òscar Reig, et al.
Pageof 3